Cellma Oncology EMR for Integrated NHS Cancer Care Services

Cancer services across the NHS and globally are managing increasing patient volumes, complex cancer staging requirements, multidisciplinary decision-making, and strict cancer waiting time targets. Oncology departments require more than standard electronic records. They require a dedicated oncology EMR designed to support modern cancer care pathways.  

Cellma connects oncology clinics, chemotherapy units, radiotherapy departments, pathology laboratories, imaging services, and multidisciplinary team (MDT) meetings within one interoperable digital ecosystem. Oncologists, oncology nurses, pharmacists, radiologists, and specialist cancer teams gain structured oncology electronic medical records covering the entire cancer treatment journey.  

With increasing service pressure across NHS and global oncology services and strict national cancer recovery targets, real-time access to cancer staging, diagnostics, chemotherapy management, and radiotherapy planning is essential. Cellma offers a secure and scalable oncology EMR solution designed specifically for the needs of NHS Trusts and cancer centres worldwide.

Aligned with NHS 10-Year Plan:

Cellma is purpose-built to support these goals through prevention-focused, digitally enabled, and integrated community care.

Core features of the Cellma Oncology EHR Solution

Structured Oncology Patient Records

Standardised templates across acute and chronic neurology pathways enable clinicians to document referrals, neurological assessment findings, imaging results, treatment plans, and long-term follow-up in line with NICE guidelines and NHS standards.

Advanced Cancer Staging
System

Cellma’s built-in cancer staging templates allow for the use of the TNM classification in recording tumours, mapping nodes and tracking metastasis, while its structured workflows facilitate accurate MDT preparation and reporting to support NHS cancer performance metrics.

Comprehensive Chemotherapy Management

Cellma provides specific modules for managing chemotherapy including regimen planning, dosage calculations, scheduling of treatments, monitoring of toxicity, and medication administration records. The integrated connection with the oncology pharmacy enhances the safety of the chemotherapy process.

Coordinated Multidisciplinary Team Workflows

Cellma facilitates the coordination of multidisciplinary teams by consolidating oncology patient records, diagnostic tests, clinical pathways, and treatment plans into one shared oncology EHR environment for use across NHS Trusts.

Integrated Diagnostics
& Imaging

Cellma has integrated with laboratory systems, pathology platforms and imaging infrastructure to provide real-time access to information about diagnostic tests as they are performed. This interoperability reduces delays in cancer treatment decisions.

Patient Portal and NHS App Integration

Integrated patient portal and NHS app connectivity allow patients to access appointments, view ophthalmology records, receive test updates, and communicate securely with NHS eye care teams.

AI-Enabled Clinical Decision
Support

AI-powered tools analyse oncology data to identify abnormal trends, prioritise urgent cases, and support early intervention across chemotherapy management and radiotherapy planning workflows.

Ambient Voice Technology and
NLP Documentation

Ambient Voice Technology (AVT) with Natural Language Processing (NLP) captures oncology consultations in real time. Clinical conversations are automatically converted into structured oncology electronic medical records, reducing manual documentation.

Interoperability Across
NHS Systems

Cellma integrates with PAS, GP Connect, Spine services, Shared Care Records, and Integrated Care Systems using HL7 and FHIR standards to support secure NHS data exchange.

Security and Governance
Compliance

The platform aligns with GDPR, NHS Digital, and Care Quality Commission (CQC) governance frameworks. Role-based access controls, encryption, and audit trails ensure secure management of oncology electronic medical records.

Benefits for Cancer Centres and Oncologists

Structured oncology electronic medical records ensure consistent oncology documentation

Accurate cancer staging supports efficient MDT decision-making

Integrated chemotherapy management strengthens medication safety

Radiotherapy records support effective radiotherapy planning

Unified Oncology EMR improves collaboration across NHS Trusts

Integrated diagnostics reduce delays in cancer treatment

Real-time dashboards help monitor cancer outcomes

Secure digital records support NHS regulatory compliance

Why NHS Teams Choose Cellma Oncology EMR

Fully compliant with NHS Digital and CQC governance standards
SNOMED CT, HL7, and FHIR-supported interoperability models
Integrated cancer staging, chemotherapy management, and radiotherapy planning workflows
Seamless integration with PAS, GP Connect, Spine, and diagnostic systems

Real-time BI dashboards for monitoring cancer outcomes and performance metrics
Supports structured oncology electronic medical records across cancer pathways
 
Compatible with NHS Innovation Accelerator and SBRI Healthcare funding programmes 
Secure, scalable deployment across NHS Trusts and global healthcare infrastructure

How Cellma Oncology EMR Supports the Future of Cancer Care

How Cellma Oncology EMR Supports the Future of Cancer Care

Integrated Eye Care Pathways
Across ICS

Cellma allows the integration of oncology referrals, diagnostics, chemotherapy units, radiotherapy departments, surgical teams, and survivorship clinics by utilising one unified Oncology EMR system. Therefore, it enhances the coordination of Integrated Care Systems and supports the national NHS cancer pathway.

Enhanced Interoperability and
Digital Health Infrastructure

Cellma improves interoperability by allowing secure integration and data exchange between hospitals, cancer centres and community services. This means that oncology clinicians have access to consistent electronic medical records across the patient journey.

Data-Driven
Oncology Services

Access to predictive analytics and reporting dashboards allows healthcare leaders to track wait times, assess available capacity and identify the results of cancer treatment. These insights support future planning and operational visibility across the NHS oncology services.

Integration with NHS Systems and Global Digital Infrastructure

Cellma is built for interoperability, ensuring smooth integration with national and international healthcare systems: 

UK Healthcare Integration 

Fully aligned with the NHS 10 Year Plan, supporting its vision for integrated, patient-centred, and digitally enabled care over the next decade. 

Global Healthcare Integration 

Built for global healthcare, enabling connected, patient-centred, and digital-first care anywhere in the world.

This ensures that Cellma is not only NHS-compliant but also adaptable to global digital health infrastructures, making it a future-ready choice for healthcare providers anywhere.

Frequently Asked Questions (FAQs)

How does Cellma Oncology EMR support cancer departments?

Cellma has defined structure for cancer related EMR workflow processes pertaining to oncology, recording things like cancer staging, chemotherapy management, radiotherapy documentation & interoperability with PAS, GP Connect & Spine Services and alignment with NHS Digital governance and CQC regulatory requirements.

Does Cellma support oncology chemotherapy and radiotherapy workflows?

Yes, the Cellma platform has dedicated modules for both Chemotherapy Management and Radiotherapy Planning, enabling oncology team members to effectively manage treatment protocols, dosing schedules & measure the outcomes of therapies provided.

Does Cellma integrate with other NHS Systems?

Yes, Cellma provides secure interoperability with existing NHS systems through the use of HL7 and FHIR standards, including all components of the PAS, GP Connect, Shared Care Records and Integrated Care Systems.

Cellma Oncology EMR for Integrated NHS Cancer Care Services